Karachi: IBL HealthCare Limited held a corporate briefing session on November 19, 2025, to present its financial performance overview for Fiscal Year (FY) 2025. The session highlighted the company’s revenue growth and profitability challenges amid a complex economic landscape.

In FY 2025, IBL HealthCare Limited recorded a revenue of 4.32 million, reflecting an increase from the previous year's 3.60 million. Despite this growth, the company's gross profit also rose to 1.45 million from 951,816 in FY 2024. However, operating expenses surged to 1.01 million in FY 2025, compared to 775,722 in FY 2024, impacting the operating profit, which stood at 437,303, a decrease from the preceding year's 176,094.

Profit before taxation was reported at 377,093, showing an improvement from 108,700 in FY 2024. The profit after taxation also increased to 208,371 from a low of 7,555 the previous fiscal year. This financial snapshot underscores the company's ability to navigate the challenging economic conditions characterized by high inflation, currency depreciation, escalating interest rates, and the imposition of a super tax.

According to information available from the Pakistan Stock Exchange (PSX), the company's financial performance reflects a moderate move in revenue growth, notwithstanding the external pressures impacting its profitability. The fiscal year was notably marked by the liquidation of excessive inventories, a decision driven by historical sales trends, which led to significant discounts in Q4 FY 2024.

Despite a compound annual growth rate (CAGR) of 6% in revenue, IBL HealthCare Limited's profitability experienced fluctuations due to the aforementioned economic factors. The financial results of FY 2025 reflect the ongoing challenges and the company's strategic maneuvers to maintain its market position within the designated healthcare market category.